These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 34511698)
21. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2 Li Z; Zhang JZH Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759 [TBL] [Abstract][Full Text] [Related]
22. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes. Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095 [TBL] [Abstract][Full Text] [Related]
23. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms. Ali A; Vijayan R Sci Rep; 2020 Aug; 10(1):14214. PubMed ID: 32848162 [TBL] [Abstract][Full Text] [Related]
24. Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent. Basit A; Ali T; Rehman SU J Biomol Struct Dyn; 2021 Jul; 39(10):3605-3614. PubMed ID: 32396773 [TBL] [Abstract][Full Text] [Related]
25. Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor. Sitthiyotha T; Chunsrivirot S Sci Rep; 2021 Aug; 11(1):15650. PubMed ID: 34341401 [TBL] [Abstract][Full Text] [Related]
26. ACE2-derived peptides interact with the RBD domain of SARS-CoV-2 spike glycoprotein, disrupting the interaction with the human ACE2 receptor. Souza PFN; Amaral JL; Bezerra LP; Lopes FES; Freire VN; Oliveira JTA; Freitas CDT J Biomol Struct Dyn; 2022 Aug; 40(12):5493-5506. PubMed ID: 33427102 [TBL] [Abstract][Full Text] [Related]
27. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins. Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301 [TBL] [Abstract][Full Text] [Related]
28. Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity. Chowdhury R; Boorla VS; Maranas CD Comput Struct Biotechnol J; 2020; 18():2573-2582. PubMed ID: 32983400 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189 [TBL] [Abstract][Full Text] [Related]
30. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex. Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435 [TBL] [Abstract][Full Text] [Related]
31. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy. Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM Viruses; 2022 May; 14(5):. PubMed ID: 35632769 [TBL] [Abstract][Full Text] [Related]
32. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations. Sakkiah S; Guo W; Pan B; Ji Z; Yavas G; Azevedo M; Hawes J; Patterson TA; Hong H Front Chem; 2020; 8():622632. PubMed ID: 33469527 [TBL] [Abstract][Full Text] [Related]
33. Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain. Low-Gan J; Huang R; Kelley A; Jenkins GW; McGregor D; Smider VV Biochem J; 2021 Oct; 478(19):3671-3684. PubMed ID: 34558627 [TBL] [Abstract][Full Text] [Related]
34. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2. Verkhivker G Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276 [TBL] [Abstract][Full Text] [Related]
35. Tinocordiside from Balkrishna A; Pokhrel S; Varshney A Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372 [TBL] [Abstract][Full Text] [Related]
37. Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV? Nguyen HL; Lan PD; Thai NQ; Nissley DA; O'Brien EP; Li MS J Phys Chem B; 2020 Aug; 124(34):7336-7347. PubMed ID: 32790406 [TBL] [Abstract][Full Text] [Related]
38. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260 [TBL] [Abstract][Full Text] [Related]
40. A novel predictor of ACE2-binding ability among betacoronaviruses. Dixson JD; Azad RK Evol Med Public Health; 2021; 9(1):360-373. PubMed ID: 34858595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]